{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:51:28Z","timestamp":1777434688333,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00198-023-06756-0","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T04:03:53Z","timestamp":1681963433000},"page":"1223-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study"],"prefix":"10.1007","volume":"34","author":[{"given":"Chao-Ming","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Tung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Kun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-921X","authenticated-orcid":false,"given":"Ming-Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-An","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"6756_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","volume":"94","author":"W Peck","year":"1993","unstructured":"Peck W (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646\u2013650","journal-title":"Am J Med"},{"key":"6756_CR2","doi-asserted-by":"crossref","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull\u00a0133(1):105\u2013117","DOI":"10.1093\/bmb\/ldaa005"},{"key":"6756_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00223-012-9671-9","volume":"92","author":"K Ili\u0107","year":"2013","unstructured":"Ili\u0107 K, Obradovi\u0107 N, Vujasinovi\u0107-Stupar N (2013) The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int 92:217\u2013227","journal-title":"Calcif Tissue Int"},{"key":"6756_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/01.HYP.16.5.515","volume":"16","author":"AS Brickman","year":"1990","unstructured":"Brickman AS, Nyby MD, von Hungen K, Eggena P, Tuck ML (1990) Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension 16:515\u2013522","journal-title":"Hypertension"},{"key":"6756_CR5","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/bmj.296.6625.814","volume":"296","author":"D Grobbee","year":"1988","unstructured":"Grobbee D, Hackeng W, Birkenh\u00e4ger J, Hofman A (1988) Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J (Clin Res Ed) 296:814\u2013816","journal-title":"Br Med J (Clin Res Ed)"},{"key":"6756_CR6","first-page":"624","volume":"120","author":"EW Young","year":"1992","unstructured":"Young EW, Morris CD, McCarron DA (1992) Urinary calcium excretion in essential hypertension. J Lab Clin Med 120:624\u2013632","journal-title":"J Lab Clin Med"},{"key":"6756_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA, Group SoOFR (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. The Lancet 354:971\u2013975","journal-title":"The Lancet"},{"key":"6756_CR8","first-page":"169","volume":"13","author":"FP Cappuccio","year":"2000","unstructured":"Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB (2000) Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13:169\u2013177","journal-title":"J Nephrol"},{"key":"6756_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00223-008-9198-2","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2009) Hypertension is a risk factor for fractures. Calcif Tissue Int 84:103\u2013111","journal-title":"Calcif Tissue Int"},{"key":"6756_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00198-021-06190-0","volume":"33","author":"D Canoy","year":"2022","unstructured":"Canoy D, Harvey NC, Prieto-Alhambra D, Cooper C, Meyer HE, \u00c5svold BO, Nazarzadeh M, Rahimi K (2022) Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions. Osteoporos Int 33:315\u2013326","journal-title":"Osteoporos Int"},{"key":"6756_CR11","doi-asserted-by":"crossref","unstructured":"Aung K, Htay T (2011) Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev\u00a0(10):005185","DOI":"10.1002\/14651858.CD005185.pub2"},{"key":"6756_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/HJH.0000000000002245","volume":"38","author":"T Bokrantz","year":"2020","unstructured":"Bokrantz T, Schi\u00f6ler L, Bostr\u00f6m KB, Kahan T, Mellstr\u00f6m D, Ljungman C, Hjerpe P, Hasselstr\u00f6m J, Manhem K (2020) Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database. J Hypertens 38:167\u2013175","journal-title":"J Hypertens"},{"key":"6756_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bmj.301.6764.1303","volume":"301","author":"R Wasnich","year":"1990","unstructured":"Wasnich R, Davis J, Ross P, Vogel J (1990) Effect of thiazide on rates of bone mineral loss: a longitudinal study. BMJ 301:1303\u20131305","journal-title":"BMJ"},{"key":"6756_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1359\/jbmr.0301214","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC (2004) \u03b2-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong osteoporosis study. J Bone Miner Res 19:19\u201324","journal-title":"J Bone Miner Res"},{"key":"6756_CR15","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of \u03b2-blockers and risk of fractures. JAMA 292:1326\u20131332","journal-title":"JAMA"},{"key":"6756_CR16","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA (2011) Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 26:1561\u20131567","journal-title":"J Bone Miner Res"},{"key":"6756_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1358\/mf.2003.25.3.769642","volume":"25","author":"S Zacharieva","year":"2003","unstructured":"Zacharieva S, Shigarminova R, Nachev E, Kamenov Z, Atanassova I, Orbetzova M, Stoynev A, Doncheva N, Borissova A (2003) Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause. Methods Find Exp Clin Pharmacol 25:209\u2013214","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"6756_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case\u2013control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"6756_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00774-012-0389-6","volume":"31","author":"S Takaoka","year":"2013","unstructured":"Takaoka S, Yamaguchi T, Tanaka K-i, Morita M, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2013) Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes. J Bone Miner Metab 31:102\u2013107","journal-title":"J Bone Miner Metab"},{"key":"6756_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0024-3205(95)02054-M","volume":"57","author":"I \u017dofkov\u00e1","year":"1995","unstructured":"\u017dofkov\u00e1 I, Kancheva R (1995) The effect of nifedipine on serum parathyroid hormone and calcitonin in postmenopausal women. Life Sci 57:1087\u20131096","journal-title":"Life Sci"},{"key":"6756_CR21","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2215\/CJN.04151206","volume":"3","author":"B Clarke","year":"2008","unstructured":"Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:S131\u2013S139","journal-title":"Clin J Am Soc Nephrol"},{"key":"6756_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"C-Y Hsieh","year":"2019","unstructured":"Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Yang Y-HK, Lai EC-C (2019) Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol 11:349","journal-title":"Clin Epidemiol"},{"key":"6756_CR23","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"C-Y Wu","year":"2012","unstructured":"Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kuo KN, Wu M-S, Lin J-T (2012) Association between nucleoside analogues and risk of hepatitis B virus\u2013related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906\u20131913","journal-title":"JAMA"},{"key":"6756_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jama.2017.13883","volume":"318","author":"S-H Chang","year":"2017","unstructured":"Chang S-H, Chou I-J, Yeh Y-H, Chiou M-J, Wen M-S, Kuo C-T, See L-C, Kuo C-F (2017) Association between use of non\u2013vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 318:1250\u20131259","journal-title":"JAMA"},{"key":"6756_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YHY, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20:236\u2013242","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6756_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/pds.4267","volume":"27","author":"WH Kao","year":"2018","unstructured":"Kao WH, Hong JH, See LC, Yu HP, Hsu JT, Chou IJ, Chou WC, Chiou MJ, Wang CC, Kuo CF (2018) Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiol Drug Saf 27:1060\u20131066","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6756_CR27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"E Siris","year":"2014","unstructured":"Siris E, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus M, Harris S, Jan de Beur S, Khosla S, Lane NE (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25:1439\u20131443","journal-title":"Osteoporos Int"},{"key":"6756_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s001980200060","volume":"13","author":"W Max","year":"2002","unstructured":"Max W, Sinnot P, Kao C, Sung H-Y, Rice DP (2002) The burden of osteoporosis in California, 1998. Osteoporos Int 13:493\u2013500","journal-title":"Osteoporos Int"},{"key":"6756_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/biomet\/74.2.289","volume":"74","author":"R Gill","year":"1987","unstructured":"Gill R, Schumacher M (1987) A simple test of the proportional hazards assumption. Biometrika 74:289\u2013300","journal-title":"Biometrika"},{"issue":"771\u2013784","key":"6756_CR30","first-page":"e776","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi TH, Scialdone A, Graja A, Gohlke S, Jank A-M, Bocian C, Woelk L, Fan H, Logan DW, Sch\u00fcrmann A (2017) Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20(771\u2013784):e776","journal-title":"Cell Stem Cell"},{"key":"6756_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2213-8587(14)70007-5","volume":"3","author":"MJ Devlin","year":"2015","unstructured":"Devlin MJ, Rosen CJ (2015) The bone\u2013fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol 3:141\u2013147","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6756_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","volume":"1","author":"J Lin","year":"2005","unstructured":"Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361\u2013370","journal-title":"Cell Metab"},{"key":"6756_CR33","doi-asserted-by":"publisher","first-page":"16887","DOI":"10.18632\/aging.103590","volume":"12","author":"L Li","year":"2020","unstructured":"Li L, Wang B, Li Y, Li L, Dai Y, Lv G, Wu P, Li P (2020) Celastrol regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing PGC-1\u03b1 signaling. Aging (Albany NY) 12:16887","journal-title":"Aging (Albany NY)"},{"key":"6756_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.stem.2018.07.010","volume":"23","author":"MC Horowitz","year":"2018","unstructured":"Horowitz MC, Tommasini SM (2018) Fat and bone: PGC-1\u03b1 regulates mesenchymal cell fate during aging and osteoporosis. Cell Stem Cell 23:151\u2013153","journal-title":"Cell Stem Cell"},{"issue":"193\u2013209","key":"6756_CR35","first-page":"e195","volume":"23","author":"B Yu","year":"2018","unstructured":"Yu B, Huo L, Liu Y, Deng P, Szymanski J, Li J, Luo X, Hong C, Lin J, Wang C-Y (2018) PGC-1\u03b1 controls skeletal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing TAZ. Cell Stem Cell 23(193\u2013209):e195","journal-title":"Cell Stem Cell"},{"key":"6756_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/j.1550-8528.1993.tb00025.x","volume":"1","author":"MJ Radin","year":"1993","unstructured":"Radin MJ, Chu YY, Hoepf TM, McCune SA (1993) Treatment of obese female and male SHHF\/Mcc-facp Rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure. Obes Res 1:433\u2013442","journal-title":"Obes Res"},{"key":"6756_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00198-008-0612-4","volume":"19","author":"S Ott","year":"2008","unstructured":"Ott S, LaCroix A, Scholes D, Ichikawa L, Wu K (2008) Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. Osteoporos Int 19:1315\u20131322","journal-title":"Osteoporos Int"},{"key":"6756_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bone.2010.10.170","volume":"48","author":"S Yang","year":"2011","unstructured":"Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2011) Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone 48:451\u2013455","journal-title":"Bone"},{"key":"6756_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"Wiens M, Etminan M, Gill S, Takkouche B (2006) Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350\u2013362","journal-title":"J Intern Med"},{"key":"6756_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ajh.2010.198","volume":"24","author":"M Iwai","year":"2011","unstructured":"Iwai M, Kanno H, Inaba S, Senba I, Sone H, Nakaoka H, Horiuchi M (2011) Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-Ay mice. Am J Hypertens 24:169\u2013174","journal-title":"Am J Hypertens"},{"key":"6756_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jbmr.2083","volume":"29","author":"P Srikanthan","year":"2014","unstructured":"Srikanthan P, Crandall CJ, Miller-Martinez D, Seeman TE, Greendale GA, Binkley N, Karlamangla AS (2014) Insulin resistance and bone strength: findings from the study of midlife in the United States. J Bone Miner Res 29:796\u2013803","journal-title":"J Bone Miner Res"},{"key":"6756_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/hr.2011.129","volume":"34","author":"Z Tian","year":"2011","unstructured":"Tian Z, Miyata K, Tabata M, Yano M, Tazume H, Aoi J, Takahashi O, Araki K, Kawasuji M, Oike Y (2011) Nifedipine increases energy expenditure by increasing PGC-1\u03b1 expression in skeletal muscle. Hypertens Res 34:1221\u20131227","journal-title":"Hypertens Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06756-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T06:05:33Z","timestamp":1687241133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6756"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06756-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}